The American Heart Association outlined several considerations for the management of pregnant women with CVD or CVD-related conditions.
Balloon pulmonary angioplasty and pulmonary vasodilators were both found to improve functional and hemodynamic outcomes in patients with inoperable chronic thromboembolic pulmonary hypertension.
Left atrial appendage thrombosis was found to occur frequently in patients who undergo transfemoral transcatheter aortic valve implantation.
An expert panel released a set of 22 guidelines for the prevention, detection, and treatment of venous thromboembolism.
Decisions regarding anticoagulation therapy for patients with COVID-19 should take into account the risk for treatment-associated bleeding, including intracranial hemorrhage.
Patients who died from COVID-19 presented mainly with pulmonary disease involving diffuse alveolar damage that led to acute respiratory insufficiency.
Despite thromboprophylaxis, patients who have newly developed multiple myeloma are at an “unacceptably high VTE risk”, study results suggest.
Administration of DOAC in combination with an antiplatelet agent may reduce the risk for hemorrhagic and embolic events in patients with nonvalvular atrial fibrillation following carotid artery stenting.
Limited tablet cardiac ultrasound was found to represent an effective alternative to standard platform imaging for the screening of COVID-19-related cardiac conditions.
Nearly 1 in 4 patients with incident venous thromboembolism were found not to initiate prescribed anticoagulation therapy in the month following hospital discharge.